Method of preparation of an ophthalmic solution of latanoprost and the solution as is produced

2004 
A method for solubilizing an active agent analogous to prostaglandin F2a, such as latanoprost, and a method for preparing an aqueous ophthalmic solution from solubilized latanoprost for the treatment of various ocular conditions is described. The present invention also concerns an aqueous ophthalmic solution resulting from the aforementioned method, which is characterized by its chemical stability at room temperature, safety, safety and efficacy in the treatment of the patient. The new aqueous ophthalmic solution is distinguished because its pharmaceutical value lies in the handling of an easily accessible vehicle that not only allows the solubility of latanoprost but also favors its chemical stability and a greater tolerance of the patient to its ophthalmic application for the treatment of your condition
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []